{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05170126",
            "orgStudyIdInfo": {
                "id": "IM047-003"
            },
            "organization": {
                "fullName": "Bristol-Myers Squibb",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring",
            "officialTitle": "ZEPOSIA\u00ae (Ozanimod) Pregnancy Registry: A Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-on-the-safety-of-ozanimod-exposure-in-pregnant-women-and-their-offspring"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-01-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2031-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2031-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-12-22",
            "studyFirstSubmitQcDate": "2021-12-22",
            "studyFirstPostDateStruct": {
                "date": "2021-12-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Bristol-Myers Squibb",
                "class": "INDUSTRY"
            }
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to provide information on maternal, fetal, and infant outcomes following exposure of ozanimod during pregnancy so that participants and physicians can weigh the benefits and risks of exposure to the pharmaceutical during pregnancy and make informed treatment decisions."
        },
        "conditionsModule": {
            "conditions": [
                "Multiple Sclerosis"
            ],
            "keywords": [
                "Multiple Sclerosis",
                "Ozanimod",
                "Pregnancy",
                "Outcomes",
                "Obstetric",
                "Infant"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": true,
            "targetDuration": "12 Months",
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 1182,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Ozanimod-exposed",
                    "description": "Pregnant women with a diagnosis of Multiple sclerosis (MS) who are exposed to ozanimod at any time during pregnancy"
                },
                {
                    "label": "Unexposed comparator cohort with MS",
                    "description": "Pregnant women with a diagnosis of MS who are not exposed to ozanimod at any time during pregnancy"
                },
                {
                    "label": "Unexposed comparator cohort without MS",
                    "description": "Pregnant women without a diagnosis of MS who are not exposed to ozanimod at any time during pregnancy"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Major congenital malformations",
                    "timeFrame": "Up to first year of life"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Minor congenital malformations",
                    "timeFrame": "Up to first year of life"
                },
                {
                    "measure": "Pre-eclampsia",
                    "timeFrame": "Through pregnancy"
                },
                {
                    "measure": "Eclampsia",
                    "timeFrame": "Through pregnancy"
                },
                {
                    "measure": "Spontaneous abortion",
                    "timeFrame": "Through pregnancy"
                },
                {
                    "measure": "Stillbirth",
                    "timeFrame": "Through pregnancy"
                },
                {
                    "measure": "Elective termination",
                    "timeFrame": "Through pregnancy"
                },
                {
                    "measure": "Preterm birth",
                    "timeFrame": "Through pregnancy"
                },
                {
                    "measure": "Small for gestational age",
                    "timeFrame": "Up to first year of life"
                },
                {
                    "measure": "Postnatal growth deficiency",
                    "timeFrame": "Up to first year of life"
                },
                {
                    "measure": "Infant developmental deficiency",
                    "timeFrame": "Up to first year of life"
                },
                {
                    "measure": "Perinatal death",
                    "timeFrame": "Up to first year of life"
                },
                {
                    "measure": "Neonatal death",
                    "timeFrame": "Up to first year of life"
                },
                {
                    "measure": "Infant death",
                    "timeFrame": "Up to first year of life"
                },
                {
                    "measure": "Serious or opportunistic infant infection (SOI)",
                    "timeFrame": "Up to first year of life"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of Multiple sclerosis (MS)\n* Currently or recently pregnant\n* Reside in a country where ozanimod is prescribed for treatment of MS\n\nExclusion Criteria:\n\n* Diagnostic prenatal test results known prior to first contact with the Registry Coordination Center (RCC)\n* Exposure to known teratogens and/or investigational medications during pregnancy\n\nOther protocol-defined inclusion/exclusion criteria apply",
            "sex": "FEMALE",
            "genderBased": true,
            "genderDescription": "Female",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "The study population will include pregnant women of any age who reside in the United States",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BMS Study Connect Contact Center www.BMSStudyConnect.com",
                    "role": "CONTACT",
                    "phone": "855-907-3286",
                    "email": "Clinical.Trials@bms.com"
                },
                {
                    "name": "First line of the email MUST contain the NCT# and Site #.",
                    "role": "CONTACT"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Bristol-Myers Squibb",
                    "affiliation": "Bristol-Myers Squibb",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Evidera",
                    "status": "RECRUITING",
                    "city": "Bethesda",
                    "state": "Maryland",
                    "zip": "20814",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kristin Veley, Site 0001",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.98067,
                        "lon": -77.10026
                    }
                },
                {
                    "facility": "Local Institution - 0002",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Herne",
                    "zip": "44625",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Site 0002",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.5388,
                        "lon": 7.22572
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "BMS Clinical Trial Information",
                    "url": "https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html"
                },
                {
                    "label": "FDA Safety Alerts and Recalls",
                    "url": "http://www.fda.gov/MEDWATCH/safety.htm"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009103",
                    "term": "Multiple Sclerosis"
                },
                {
                    "id": "D000012598",
                    "term": "Sclerosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000020278",
                    "term": "Demyelinating Autoimmune Diseases, CNS"
                },
                {
                    "id": "D000020274",
                    "term": "Autoimmune Diseases of the Nervous System"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000003711",
                    "term": "Demyelinating Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12060",
                    "name": "Multiple Sclerosis",
                    "asFound": "Multiple Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15415",
                    "name": "Sclerosis",
                    "asFound": "Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22098",
                    "name": "Demyelinating Autoimmune Diseases, CNS",
                    "relevance": "LOW"
                },
                {
                    "id": "M22094",
                    "name": "Autoimmune Diseases of the Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M6909",
                    "name": "Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M216548",
                    "name": "Ozanimod",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}